HF
VOR icon

HRT Financial’s Vor Biopharma VOR Stock Holding History

HRT Financial’s Portfolio VOR Stock Details VOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-23,729
Closed -$768K – 3744
2025
Q2 		$768K Buy
+23,729
New +$210K ﹤0.01% 1391
2024
Q3 		– Sell
-1,593
Closed -$31K – 3197
2024
Q2 		$31K Buy
+1,593
New +$51.5K ﹤0.01% 1889
2023
Q2 		– Sell
-2,069
Closed -$222K – 3351
2023
Q1 		$222K Buy
2,069
+1,173
+131% +$130K ﹤0.01% 1881
2022
Q4 		$119K Buy
+896
New +$88.7K ﹤0.01% 2036
2022
Q2 		– Sell
-3,171
Closed -$383K – 3796
2022
Q1 		$383K Buy
3,171
+2,109
+199% +$359K ﹤0.01% 2056
2021
Q4 		$246K Buy
+1,062
New +$306K ﹤0.01% 2398

Other funds holding VOR

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACM
Ariose Capital Management Central, Hong Kong, Hong Kong $149M AUM 287.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HRT Financial's VOR Position: Q3 2025 in Review

HRT Financial sold out of Vor Biopharma (VOR) in Q3 2025, closing a stake of 23,729 shares — an estimated $768K sold.

HRT Financial first reported a position in VOR in Q4 2021 and held it in 6 quarters. The position peaked at $768K in Q2 2025. 37 funds tracked by Wall St. Rank hold VOR as of Q3 2025.

  • HRT Financial reported no remaining Vor Biopharma position as of Q3 2025 after selling out during the quarter.
  • HRT Financial sold 23,729 Vor Biopharma shares in Q3 2025, an estimated $768K.
  • HRT Financial first reported a position in Vor Biopharma in Q4 2021 and held it in 6 quarters.
  • HRT Financial's Vor Biopharma position peaked at $768K in Q2 2025.
  • 37 funds tracked by Wall St. Rank held Vor Biopharma as of Q3 2025.

Based on HRT Financial's 13F filing for Q3 2025, filed 14 Nov 2025.